S. Durán‐García

Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin

Michael A. Nauck, Stefano Del Prato, Juris J. Meier et al. · Diabetes Care · 2011 · 527 citations · Full text

Long‐term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add‐on therapy to metformin in patients with type 2 diabetes: 4‐year data

Stefano Del Prato, Michael A. Nauck, S. Durán‐García et al. · Diabetes Obesity and Metabolism · 2015 · 226 citations

Effects of Adding Linagliptin to Basal Insulin Regimen for Inadequately Controlled Type 2 Diabetes

Hannele Yki‐Järvinen, Julio Rosenstock, S. Durán‐García et al. · Diabetes Care · 2013 · 132 citations · Full text

Durability of glycaemic efficacy over 2 years with dapagliflozin versus glipizide as add‐on therapies in patients whose type 2 diabetes mellitus is inadequately controlled with metformin

Michael A. Nauck, Stefano Del Prato, S. Durán‐García et al. · Diabetes Obesity and Metabolism · 2014 · 114 citations

A randomized trial comparing perinatal outcomes using insulin detemir or neutral protamine Hagedorn in type 1 diabetes

Moshe Hod, Elisabeth R. Mathiesen, Lois Jovanovič et al. · The Journal of Maternal-Fetal & Neonatal Medicine · 2013 · 98 citations · Full text